Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 2

Abstract

Neuroleptic malignant syndrome (NMS) is the most dangerous life-threatening complication of antipsychotic medication. It's development is connected with the blockade of dopaminergic transmission (D2 receptors) in the nigrostriatal system of the brain. Fever is one of the main symptoms of this syndrome and it's elevation is due to the activation of the immune system. Numerous studies report that treatment with clozapine (doses 37.5-600 mg) or olanzapine (doses 10-25 mg) or the use of these drugs in polytherapy cause pyrexia between 37.8-40.6°C. Additionally, levels of proinflammatory interleukins such as IL-6, IL-1,TNF-α were increased. The aim of this article is to describe how olanzapine and clozapine influence fever development in NMS, in relation to the dose of the drug taken by schizophrenic patients including changes in immunological system.

Authors and Affiliations

Anna Szota, Ewa Ogłodek, Aleksander Araszkiewicz

Keywords

Related Articles

Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro.

Long-term administration of heparin can lead to development of osteoporosis. The aim of the present study was to examine the effects of standard heparin and low-molecular-weight heparins (nadroparin, enoxaparin, parnapar...

Anxiogenic effect of CCK8s in the ventral hippocampus of rats: possible involvement of GABA(A) receptors.

Cholecystokinin (CCK) as an important neuropeptide in the brain has been implicated in the modulation of anxiety. The effects of this neurotransmitter on anxiety-like behavior in the ventral hippocampus have not been eva...

Neuroprotective effects of MTEP, a selective mGluR5 antagonists and neuropeptide Y on the kainate-induced toxicity in primary neuronal cultures.

The majority of studies on neuroprotection tested potentially protective compounds given before, simultaneously or shortly after damage. Such procedures are greatly different from the situation faced in clinical practice...

Neuroprotective properties of statins.

Treatment with statins (3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors) reduces the risk of ischemic stroke among patients with increased risk of vascular disease. Recent experimental data point to neuroprote...

Impact of postnatal dexamethasone on psychotomimetic effects of MK-801 measured on adult rats.

The present study investigates the impact of dexamethasone (DEX) given in tapering doses in the postnatal period on MK-801-induced locomotor activity and MK-801-evoked deficits of sensorimotor gating of adult rats (60 da...

Download PDF file
  • EP ID EP156743
  • DOI -
  • Views 98
  • Downloads 0

How To Cite

Anna Szota, Ewa Ogłodek, Aleksander Araszkiewicz (2013). Fever development in neuroleptic malignant syndrome during treatment with olanzapine and clozapine.. Pharmacological Reports, 65(2), 279-287. https://europub.co.uk./articles/-A-156743